查詢結果分析
相關文獻
- Visual Association Memory Test in Differentiating Early Stage of Alzheimer's Disease from Vascular Dementia
- Increased Hippocampal Nerve Growth Factor Following Beta-Amyloid Peptide Treatment in Rats
- 癡呆症藥物治療的趨勢與展望
- 藥物經濟學(2):綜觀膽鹼酯酶抑制劑在阿滋海默症的藥物經濟效益
- 藥物經濟學簡介(1):阿滋海默症的疾病成本
- 阿爾茲海瑪氏病[Alzheimer's Disease]與血管性痴呆症[Vascular Dementia]
- 阿滋海默癡呆 (失智) 症研究近況
- 退化性失智症成因及臨床特徵介紹
- 高溫超導量子干涉元件在阿滋海默症生物標記早期檢測之臨床應用
- 探討溝通概念與技巧『如何與老人和失智症患者保持和諧之關係』
頁籤選單縮合
題 名 | Visual Association Memory Test in Differentiating Early Stage of Alzheimer's Disease from Vascular Dementia=視覺相關記憶測驗區分早期阿茲海默氏病和血管性痴呆症研究 |
---|---|
作 者 | 莊雯莉; 王宣閔; 謝玉珍; 張庭芳; 郭弘周; 黃錦章; | 書刊名 | Acta Neurologica Taiwanica |
卷 期 | 15:2 民95.06 |
頁 次 | 頁98-104 |
分類號 | 415.8471 |
關鍵詞 | 視覺相關記憶測驗; 阿滋海默症; 血管性痴呆症; Visual association memory test; CDR; MMSE; Neuropsychology; Vascular dementia; Alzheimer's disease; |
語 文 | 英文(English) |
英文摘要 | Abstract- We studied the results of the Visual Association Memory Test (VAMT) in differentiating Alzheimer's disease (AD) and vascular dementia (VaD). In addition, other basic neuropsychological tests, including the Mini-Mental State Examination (MMSE) and the Clinical Dementia Rating (CDR) were also used. Generally, with the VAMT, AD patients had a worse performance than VaD patients. Particularly among patients with a CDR=0.5, the AD patients had statistically significantly lower VAMT scores (score less than 3) (p=0.026) compared to those of VaD patients. However, the VAMT could not predict clinical severity or disease progression. The VAMT as revealed in this study, is a brief, simply administered, and less biased test, and may offer a diagnostic adjunct to differentiate AD from VaD especially in an early dementia state. |
本系統中英文摘要資訊取自各篇刊載內容。